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Abstract
Transcranial direct current stimulation (tDCS) is increasingly being used in human studies as an adjuvant tool to promote
recovery of function after stroke. However, its neurobiological effects are still largely unknown. Electric fields are known to
influence the migration of various cell types in vitro, but effects in vivo remain to be shown. Hypothesizing that tDCS might
elicit the recruitment of cells to the cortex, we here studied the effects of tDCS in the rat brain in vivo. Adult Wistar rats
(n = 16) were randomized to either anodal or cathodal stimulation for either 5 or 10 consecutive days (500 mA, 15 min).
Bromodeoxyuridine (BrdU) was given systemically to label dividing cells throughout the experiment. Immunohistochemical
analyses ex vivo included stainings for activated microglia and endogenous neural stem cells (NSC). Multi-session tDCS with
the chosen parameters did not cause a cortical lesion. An innate immune response with early upregulation of Iba1-positive
activated microglia occurred after both cathodal and anodal tDCS. The involvement of adaptive immunity as assessed by
ICAM1-immunoreactivity was less pronounced. Most interestingly, only cathodal tDCS increased the number of endogenous
NSC in the stimulated cortex. After 10 days of cathodal stimulation, proliferating NSC increased by ,60%, with a significant
effect of both polarity and number of tDCS sessions on the recruitment of NSC. We demonstrate a pro-inflammatory effect
of both cathodal and anodal tDCS, and a polarity-specific migratory effect on endogenous NSC in vivo. Our data suggest
that tDCS in human stroke patients might also elicit NSC activation and modulate neuroinflammation.
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Introduction
Transcranial direct current stimulation (tDCS) has long been
known to induce long-lasting alterations of cortical excitability
both in experimental animals [1] and humans [2]. It has been used
as a reversible neuromodulation technique to study the behavioral
impact of distinct neural networks in experimental animals [3].
Given further results demonstrating that non-invasive brain
stimulation enhances the effects of motor learning in healthy
volunteers [4,5], recent studies have tried to exploit the therapeutic
potential of the method for various neurological and psychiatric
disorders. Studies in human stroke patients have shown tDCS to
be a promising therapeutic intervention to ameliorate motor
deficits [6], aphasia [7], and neglect [8], suggesting that tDCS may
become a new adjuvant tool to promote recovery of function after
stroke [9]. Although tDCS is already widely used in human
studies, the basic mechanisms of its action remain incompletely
explored, and details about the neurobiological effects of tDCS are
still unknown (for comprehensive reviews, see [10,11]. The long-
lasting effects on cortical excitability outlasting the actual
stimulation (‘after-effects’) seem to depend on alterations of resting
membrane potentials and NMDA-receptor dependent synaptic
plasticity [12]. However, it was recently reported that the impact
of tDCS exceeds those primary electrophysiological effects, as
tDCS was shown to modulate cerebral blood flow in a polarity-
specific way, potentially via neuro-vascular coupling [13]. More-
over, recent theoretical calculations suggested alterations in the
transmembrane potential of glial cells rather than neurons,
challenging the view that the effects of tDCS effects are neuronally
driven, and refocusing the search for its neurobiological effects on
non-neuronal cell populations [14]. Studies in vitro have shown that
electric fields induce cultured cells to migrate, a phenomenon
referred to as galvanotaxis [15]. This has been demonstrated for
various types of cells, among them fibroblasts [16], granulocytes
[17], and keratinocytes [18]. Interestingly, recent reports have also
found rodent neural progenitor cells [19,20], human embryonic
stem (ES) cells [21], and human ES-cell derived neural stem cells
[22] to migrate in the electric field in vitro. However, whether such
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effects can also be observed in vivo has not yet been investigated.
We hypothesized that tDCS may attract cells inflicted in
reparative responses after stroke. This is a proof of principle
study, and in order not to miss subtle effects, we stimulated adult
rats with high current density, but, importantly, below lesion
threshold.
Materials and Methods
Animals and Surgery
All animal procedures were in accordance with the German
Laws for Animal Protection and were approved by the local
animal care committee and local governmental authorities.
Spontaneously breathing male Wistar rats weighing 290–330 g
were anesthetized with 5% isoflurane and maintained with 2.5%
isoflurane in 65% / 35% nitrous oxide / oxygen. Throughout
surgical procedures, body temperature was maintained at 37.0uC
with a thermostatically controlled heating pad.
Multi-session transcranial direct current
stimulation. An epicranial electrode with a defined contact
area of 3.5 mm2 was mounted onto the intact skull using non-toxic
glass ionomer luting cement (Ketac Cem Plus, 3 M ESPE, Seefeld,
Germany) at the following stereotaxic coordinates: bregma AP
+2.0 mm, ML +2.0 mm. After electrode placement, the skin
around the electrode was closed with sutures, and the electrode left
in place for the entire experiment. The counter electrode was
placed on the rat’s ventral thorax. tDCS was applied continuously
for 15 min at 500 mA using a constant current stimulator (CX-
6650, Schneider Electronics, Gleichen, Germany), according to
the protocol by Liebetanz et al [23]. The chosen parameters led to
a charge density (current x time / area) of 128571 C / m2. tDCS
was performed under anesthesia to avoid dislocation of the cable.
At the first day of the experiment, animals were randomized to
either anodal (n = 6) or cathodal (n = 10) tDCS. tDCS was
repeated daily using the same parameters for a total of 5
consecutive days, followed by a tDCS-free interval of 3 days.
Eight out of 16 animals were sacrificed for histology at that time
point, while another 8 animals were subjected to tDCS for 5 more
days (n = 3 anodal, n = 5 cathodal), resulting in a total of 10 days
of tDCS. After each procedure, all animals were allowed to
recover from anesthesia and were put back into their home cages,
where they were given access to food and water ad libitum.
BrdU injections. In all animals, the tracer bromodeoxyur-
idine (BrdU) was injected intraperitoneally for the duration of the
experiment, starting on the first day of tDCS, at a concentration of
50 mg/kg per injection, as described previously [24]. Animals
receiving 5 sessions of tDCS were injected with 50 mg/kg BrdU
per injection daily just prior to each tDCS session. Animals
receiving 10 sessions of tDCS were injected every other day. This
regime resulted in a cumulative dose of 250 mg/kg BrdU per
animal.
Immunohistochemistry
Three days after the last tDCS session, rats were deeply
anesthetized and decapitated. The brains were rapidly removed,
frozen in isopentane at 240uC, and stored at 280uC prior to
further histological and immunohistochemical processing. Ten mm
thick adjacent serial coronal brain sections were cut at 500 mm
intervals. H&E staining was performed according to standard
protocols to detect any cortical lesion due to tDCS. For
immunohistochemistry, sections were fixed with either 4%
paraformaldehyde (for Iba1, BrdU, and Hes3-stainings), or with
100% acetone (for ICAM1-stainings). For antigen-retrieval prior
to BrdU-staining, sections were microwave-heated in 0.01 M
citrate buffer, pH 6.0, for 5 min, followed by 2N HCl at 37uC for
30 min. The following antibodies were used: anti-Iba1 (rabbit
polyclonal, cat# 019-19741, dilution 1:1000, Wako, Neuss,
Germany); anti-ICAM-1 (mouse monoclonal, anti-rat CD54,
Figure 1. Multi-session transcranial DCS with defined parameters does not cause a cerebral lesion or astrogliotic scar. (A) For multi-
session tDCS, an epicranial electrode was mounted as schematically depicted (red circle). (B) H&E staining confirmed an intact cortex after multi-
session focal tDCS, and (C) no astrogliotic scarring was detected by GFAP staining (scale bar = 1 mm).
doi:10.1371/journal.pone.0043776.g001
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cat-# MCA773GA, dilution 1:500, AbD Serotec, Puchheim,
Germany); anti-BrdU (mouse monoclonal, cat-# B2531, dilution
1:100, Sigma, Munich, Germany); anti-Hes3 (rabbit polyclonal,
cat-# sc-25393, dilution 1:1000, Santa Cruz Biotechnology,
Heidelberg, Germany). For visualization of all antibodies, the
ABC Elite kit (Vector Laboratories, Burlingame, CA, USA) with
diaminobenzidine (Sigma, Munich, Germany) as the final reaction
product was used.
Quantification and statistical analysis
To determine the number of Iba1-positive, BrdU-positive and
Hes3-positive cells and of ICAM1-positive vessels in the cortex, 20
coronal sections at 500 mm intervals were stained with the
respective antibody. Using a Zeiss Axiophot microscope with a
40x objective, 7 images of adjacent fields of view (FOV) of the
cortex were taken of each hemisphere, and of each section. The
number of positive cells in the ipsilateral, stimulated hemisphere
was divided by the corresponding number in the contralateral,
control hemisphere. Mean values and standard errors of the mean
of these ratios were calculated for each group of animals that had
received the same treatment.
Descriptive statistics and Student’s t-tests were performed with
Microsoft Excel 2003 (Microsoft Corp.); statistical significance was
set at the less than 5% level (p,0.05).
Results
Multi-session tDCS with defined parameters did not
cause a cerebral lesion or astrogliotic scar
Rats were subjected to 15 min sessions of tDCS using a
3.5 mm2 epicranial electrode and a current of 500 mA (Fig. 1A).
This protocol resulted in a charge density (current x time / area) of
128571 C / m2 per single tDCS session. No epileptic seizures or
neurological deficits were induced by tDCS.
After 5 or 10 sessions of anodal or cathodal tDCS, histological
analyses revealed that none of the rats had suffered a cortical
lesion (Fig. 1B). As assessed by GFAP immunoreactivity, tDCS
had neither caused an astrogliotic scar in the stimulated cortex
(Fig. 1C).
Multi-session tDCS activated cortical microglia. To
assess the effects of tDCS on innate neuroinflammatory processes,
rat brains were stained for Iba1, labelling activated microglia. In
Figure 2. Multi-session tDCS activates cortical microglia. (A) The density of activated microglia identified by Iba1 immunoreactivity was
increased in the cortex ipsilateral to multi-session tDCS (scale bar = 0.05 mm). (B) This increase in Iba1+ cells compared to the respective contralateral
hemisphere was most pronounced early after cathodal tDCS, but also present after anodal stimulation; effects decreased with time (means 6 SEM;
*p = 0.05, **p,0.01).
doi:10.1371/journal.pone.0043776.g002
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the ipsilateral (stimulated) cortex, the number of Iba1-positive cells
was increased after both cathodal and anodal stimulation (Fig. 2A).
This upregulation of Iba1-positive microglia by 28% was most
pronounced early (5 days) after cathodal tDCS (p,0.01) and
decreased again with time; anodal tDCS also caused early
microglial activation, but to a lesser extent (Fig. 2B).
To explore a secondary involvement of adaptive immunity, we
investigated the endothelial intercellular adhesion molecule-1
(ICAM1), involved in leukocyte transmigration through the
blood-brain barrier. After 5 days, ICAM-1 was increased by
trend in the ipsilateral (stimulated) cortex, irrespective of the
polarity (Fig. 3A). While cathodal stimulation tended to further
increase ICAM1-positive vessels with time, the trend was only
transient after anodal tDCS (Fig. 3B).
Cathodal tDCS increased the number of NSC in the
cortex. During the 5 or 10 days of multi-session tDCS, animals
were repeatedly injected i.p. with BrdU to label proliferating cells.
The protocol ensured that all animals received the same
cumulative dose of BrdU, regardless of the duration of the
experiment. BrdU-positive cells were counted in the ipsilateral
cortex and compared to the contralateral side (Fig. 4A). Cathodal
stimulation of 5 days significantly increased the number of BrdU-
positive cells by 29% (p,0.01). Cathodal tDCS for 10 days
increased BrdU-positive cells by 59% (p,0.01), indicating a
significant effect of the number of tDCS sessions (p,0.05). In
contrast, anodal tDCS for 5 or 10 days did not have an effect on
the number of BrdU-positive cells in the cortex (Fig. 4B).
To further investigate what subpopulations of potentially
proliferating cells were expanded by cathodal tDCS, brains were
stained for Hes3 as a marker of endogenous NSC (Fig. 5A). The
number of Hes3-positive cells was increased by trend in the
ipsilateral (stimulated) hemisphere following 5 days of cathodal
tDCS. Increasing the number of tDCS sessions to 10 significantly
elevated Hes3-positive NSC numbers by 67% (p,0.05; Fig. 5B).
Discussion
In this study, we investigated the effects of multi-session tDCS
on the adult rat brain in vivo, focusing on the cellular responses to
stimulation. We demonstrate a pro-inflammatory effect of both
cathodal and anodal tDCS that tends to be transient. In addition,
only cathodal tDCS induced the recruitment of proliferating NSC
Figure 3. Multi-session tDCS leads to ICAM1 upregulation. (A) ICAM1 immunoreactivity was increased in the ipsilateral hemisphere after
multi-session cathodal or anodal tDCS, (scale bar = 0.2 mm). (B) ICAM1+ vessels trended to increase with time upon cathodal tDCS, while anodal
tDCS caused only a transient increase (note that differences were not statistically significant; means 6 SEM).
doi:10.1371/journal.pone.0043776.g003
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to the stimulated hemisphere. Our data suggest a polarity-specific
migratory effect on endogenous neural stem cells in vivo. tDCS is
capable of attracting cells inflicted in reparative and regenerative
responses to the site of ischemic stroke. Beneficial effects of tDCS
may at least result partly from NSC activation and the modulation
of neuroinflammation.
In our experimental paradigm, we took great care to ensure that
tDCS would not cause any lesion to the brain tissue. In a recent
pioneer study, Liebetanz et al. described the relationship between
charge density and the occurrence and size of cortical lesions [25].
While we confirmed that the charge density of 128571 C/m2 per
single tDCS session was not associated with cortical lesions, it
should be noted that the charge density used in our study is several
orders of magnitude higher than the charge density usually applied
in humans (up to 480 C/m2). We chose this high charge density –
just below the lesion threshold – in order to detect any putatively
faint effect of tDCS on cellular processes. Using this high charge
density in multi-session tDCS sessions allowed us to detect the
expected effects at a magnitude that reached statistical signifi-
cance. We hypothesize that lower charge densities as applied in
humans may have the same effects, albeit to a potentially lesser
extent. Focusing on a proof of principle design, we did not titrate
the tDCS stimulation density in this study.
We found the numbers of Iba1-positive cells to be increased
early after cathodal tDCS, decreasing again with time. Similar
findings were obtained after anodal tDCS, albeit to a lesser extent.
This rapid and transient activation of resident microglia is typical
for an innate neuroinflammatory response to tDCS. ICAM1
expression is a prerequisite of recruitment of haematogenous cells
in an antigen specific manner, categorized as adaptive immunity.
ICAM-1 was used as an indicator of upcoming adaptive immune
responses. It showed a typical later time-course with a maximum
at 10 days following cathodal stimulation, while anodal stimula-
tion caused a more transient, unspecific effect. However, those
neuroinflammatory processes observed after both cathodal and
anodal stimulation could – at least in part – also be caused by
thermal effects that were sub-threshold to induce a lesion to the
brain tissue.
Based upon work in focal cerebral ischemia, neuroinflammation
has already been characterized as a ‘double-edged sword’ with
both beneficial and detrimental effects on the prevention of
secondary tissue damage, regeneration and recovery [26].
Destructive effects of neuroinflammation include the damage
caused by reactive oxygen species and excessive production of pro-
inflammatory cytokines by immune cells, beneficial aspects are the
containment of necrotic tissue and the induction of a strong
regenerative response including the recruitment of endogenous
NSC [26–28]. Quality, extent and timing of neuroinflammatory
processes determine whether manipulating that particular re-
sponse will be deleterious or therapeutically beneficial. The
activation of resident microglia can under some circumstances
be neurotoxic [29], especially when the mode of activation triggers
Figure 4. Cathodal tDCS increases the number of proliferating cells in the cortex. (A) After multi-session cathodal tDCS, the number of
proliferating cells identified by BrdU-incorporation was increased in the ipsilateral hemisphere (scale bar = 0.5 mm). (B) This effect was only observed
with cathodal stimulation. Anodal tDCS had no effect on proliferation in the cortex (means 6 SEM; **p,0.01, *p,0.05).
doi:10.1371/journal.pone.0043776.g004
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a defense-oriented reaction, such as the application of bacterial
endotoxin lipopolysaccharide (LPS). But the engagement of
microglia can also be neuroprotective, since ablation of microglial
cells in stroke mice leads to a significant increase in infarct size
[30]. The difference in the role and function of microglia seems to
depend on the activating conditions [31]. Interestingly, differen-
tially activated microglia also have opposing effects on NSC:
microglia activated by LPS attenuate neurogenesis, while their
activation by cytokines associated with T-helper cells promotes
neurogenesis [32]. In our model of non-lesional tDCS, we propose
that cathodal tDCS induces a local immune response, predom-
inantly involving innate immunity, potentially conferring neuro-
protection and attracting endogenous NSC. However, further
experiments are needed to characterize the complex neuroin-
flammatory pattern following tDCS and the putative interplay
between NSC and inflammation.
The transcription factor Hes3 was recently identified as a
biomarker for a widespread population of quiescent endogenous
NSC that is dynamically upregulated upon their activation [33].
Several recent reports have demonstrated the direct effect of
electric fields on the migration of stem cells in culture. This has
been shown in adult mouse NSC from the subventricular zone
[19], adult rat NSC from the hippocampus [34], embryonic rat
NSC from the lateral ganglionic eminence [20], human embryonic
stem (hES) cells and human induced pluripotent stem (hiPS) cells
[21], and hES cell-derived NSC [22]. All of those cell types were
reported to migrate towards the cathode of the electric field,
except the hiPS cells that moved towards the anode [21].
Accordingly, we here show an upregulation of proliferating NSC
in the non-invasively stimulated brain after cathodal tDCS can
also be explained by the migration of endogenous NSC towards
the cathode. The extent of eNSC accumulation after cathodal
tDCS was comparable to that induced pharmacalogically, e.g. via
activation of the Notch receptor [33]. Enhancing the (physiolog-
ical) mobilization of eNSC after injury such as stroke was
previously shown to remarkably improve neurological function
and recovery [35–37]. However, the differentiation of mobilized
eNSC into mature neurons that functionally integrate into the
damaged circuitry has rarely been observed, and the vast majority
of newly generated migrating neuroblasts in ischemic stroke
models die by the time they have reached the peri-infarct area
[38]. Recent studies have elucidated several mechanisms other
than neurogenesis that convey the stem cells’ beneficial effects. An
important function of eNSC seems to be neuroprotection [33,39],
with neuroprotective effects mediated through several neuropro-
tective cytokines such as GDNF, VEGF, and Shh [35,40,41].
Other functions of eNSC in regeneration involve the suppression
of inflammation in the damaged tissue, and clearance of debris in
the injured area such as the peri-infarct tissue [42,43].
Although BrdU-positive proliferating cells could at least in part
constitute microglia, the extent of their upregulation and their
exclusive appearance after cathodal tDCS makes it likely that at
least the majority of those proliferating cells are not microglia.
Furthermore, we found the number of Hes3-positive cells to
increase with the number of cathodal tDCS session, further
confirming an effect on NSC. In addition to the direct effect of the
Figure 5. Cathodal tDCS increases the number of Hes3-positive neural stem cells in the cortex. (A) The density of NSC identified by Hes3
immunoreactivity was increased in the cortex ipsilateral to multi-session tDCS (scale bar = 0.05 mm). (B) The number of Hes3-positive NSC increased
in the ipsilateral hemisphere with the duration of cathodal tDCS (means 6 SEM; *p,0.05).
doi:10.1371/journal.pone.0043776.g005
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electric field on NSC migration, a second mechanism for the
activation of cortical NSC is conceivable: tDCS was recently
shown to modulate cerebral blood flow in a polarity-specific way,
with an increase after anodal and decrease after cathodal
stimulation, lasting for at least 30 min after tDCS [13]. Transient
ischemic stress caused by a brief decrease in blood flow is well
known to induce the proliferation of endogenous NSC, conferring
a certain ischemic tolerance in the process [44].
This study provides evidence that electric stimulation modulates
responses of non-neuronal cells in the brain, and relevantly
contributes to our scarce knowledge about the neurobiological
effects of tDCS. tDCS both attracts endogenous NSC and
activates innate immune responses. From the clinical point of
view, applying tDCS after stroke may help to locally augment
endogenous NSC known to promote neuroprotection and repair.
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